Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Squamous Cell Tumors of the Head and Neck (HNSCC)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT02976051
What this trial is testing

DAHANCA 33: Image Guided Dose-escalated Radiotherapy to Patients With Hypoxic HNSCC

Who this might be right for
Locally Advanced Head and Neck CancerRadiotherapyHypoxic Radioresistance
Danish Head and Neck Cancer Group 60
Testing effectiveness (Phase 2)Study completedNCT00671437
What this trial is testing

Determine Tumor Response Using Fluorodeoxyglucose (FDG)- Positron Emission Tomography (PET)/Computed Tomography (CT) Before and After Cetuximab in Patients With Head and Neck Cancer

Who this might be right for
Carcinoma, Squamous Cell
Washington University School of Medicine 42
Testing effectiveness (Phase 2)Study completedNCT02268695
What this trial is testing

Platinum-Cetuximab Combined With Docetaxel or With 5FU in Patients With Recurrent/Metastatic HNSCC

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Groupe Oncologie Radiotherapie Tete et Cou 541
Not applicableUnknownNCT04117139
What this trial is testing

The Diagnostic Value of PET/MRI in Head and Neck Cancer

Who this might be right for
Squamous Cell Carcinoma of Head and NeckHead and Neck NeoplasmsLymph Node Metastases
Odense University Hospital 142
Not applicableUnknownNCT01210872
What this trial is testing

Quality-Of-Life Assessment in Patients With Head and Neck Cancer Treated With Radiation Therapy

Who this might be right for
Head and Neck Cancer
Centre Georges Francois Leclerc 200
Testing effectiveness (Phase 2)Study completedNCT04326257
What this trial is testing

Personalized Immunotherapy in Patients With Recurrent /Metastatic SCCHN That Have Progressed on Prior Immunotherapy

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Dan Zandberg 20
Testing effectiveness (Phase 2)Looking for participantsNCT06993844
What this trial is testing

Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsAdvanced Breast Cancer
Ensem Therapeutics 233
Early research (Phase 1)Ended earlyNCT02437916
What this trial is testing

Safety Study of AMG 228 to Treat Solid Tumors

Who this might be right for
Advanced MalignancyAdvanced Solid TumorsCancer+8 more
Amgen 30
Testing effectiveness (Phase 2)Ended earlyNCT03829501
What this trial is testing

A Phase 1/2, Open-label, Multi-center Study of the Safety and Efficacy of Alomfilimab (KY1044) as Single Agent and in Combination With Anti-PD-L1 (Atezolizumab) in Adult Patients With Selected Advanced Malignancies

Who this might be right for
Squamous Cell Carcinoma of Head and NeckNon-small Cell Lung CancerHepatocellular Carcinoma+9 more
Kymab Limited 222
Testing effectiveness (Phase 2)Looking for participantsNCT06087614
What this trial is testing

Dose Escalation Using Hypoxia-adjusted Radiotherapy

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Rajiv Gandhi Cancer Institute & Research Center, India 124
Testing effectiveness (Phase 2)Ended earlyNCT02345330
What this trial is testing

Trial of pIL-12 Electroporation in Squamous Cell Carcinoma of the Head and Neck (IL12HNSCC)

Who this might be right for
Head and Neck Squamous Cell Carcinoma
OncoSec Medical Incorporated 4
Testing effectiveness (Phase 2)Study completedNCT01941992
What this trial is testing

Role of SAMITAL® in the Relief of Chemo-radiation (CT-RT) Induced Oral Mucositis in Head and Neck Cancer Patients

Who this might be right for
Head-and-neck Squamous Cell CarcinomaOral Mucositis
Istituto Oncologico Veneto IRCCS 120
Early research (Phase 1)Active Not RecruitingNCT05540899
What this trial is testing

Testing the Safety of Giving a Standard Dose of Radiation Over a Shorter Period of Time for Patients Who Had Surgery for Intermediate-Risk Head and Neck Cancer

Who this might be right for
Head and Neck CancerHead and Neck Squamous Cell CarcinomaSquamous Cell Carcinoma of the Larynx+2 more
American College of Radiology 14
Testing effectiveness (Phase 2)WithdrawnNCT00233636
What this trial is testing

Iressa and Radiotherapy in the Treatment of the Locally Advanced Inoperable Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Head and Neck CancerCarcinoma, Squamous Cell
AstraZeneca 28
Large-scale testing (Phase 3)Study completedNCT00003809
What this trial is testing

Cisplatin With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Eastern Cooperative Oncology Group
Large-scale testing (Phase 3)Ended earlyNCT00113399
What this trial is testing

Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery

Who this might be right for
Head and Neck Cancer
Radiation Therapy Oncology Group 15
Testing effectiveness (Phase 2)Study completedNCT01283334
What this trial is testing

Carboplatin, Cetuximab and RAD001 in Advanced Head and Neck Cancer

Who this might be right for
Head and Neck NeoplasmsCancer of the Head and Neck
Emory University 20
Early research (Phase 1)Study completedNCT04830592
What this trial is testing

NG-641 and Pembrolizumab in Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Akamis Bio 36
Not applicableLooking for participantsNCT06336941
What this trial is testing

"Ultra-High Frequency intraOral UltraSonography of the TONgue" (HOUSTON)

Who this might be right for
Oral Squamous Cell Carcinoma
University of Pisa 400
Testing effectiveness (Phase 2)Study completedNCT00063895
What this trial is testing

Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer, Ovarian Cancer, or Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Recurrent Non-small Cell Lung CancerRecurrent Ovarian Epithelial CancerRecurrent Squamous Cell Carcinoma of the Hypopharynx+27 more
National Cancer Institute (NCI) 80
Next Page